Informações:
Falhas:
ID
12454
Descrição
European Long-acting Antipsychotics in Schizophrenia Trial; ODM derived from: https://clinicaltrials.gov/show/NCT02146547
Link
https://clinicaltrials.gov/show/NCT02146547
Palavras-chave
Versões (1)
- 20/11/2015 20/11/2015 -
Transferido a
20 de novembro de 2015
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Schizophrenia DRKS00007568 NCT02146547
Eligibility Schizophrenia NCT02146547
- StudyEvent: Eligibility
Similar models
Eligibility Schizophrenia NCT02146547
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Diagnosis of schizophrenia
Item
1. diagnosis of schizophrenia as defined by dsm-iv-r (diagnostic and statistical manual) as determined by the m.i.n.i.plus
boolean
C0036341 (UMLS CUI [1])
Age
Item
2. age 18 or older.
boolean
C0001779 (UMLS CUI [1])
First psychosis
Item
3. the first psychosis occurred at least one year and no more than 7 years ago.
boolean
C3887134 (UMLS CUI [1])
Antipsychotic drug
Item
4. if patients are using an antipsychotic drug, a medication switch is currently under consideration.
boolean
C0040615 (UMLS CUI [1])
Informed consent
Item
5. capable of providing written informed consent
boolean
C0021430 (UMLS CUI [1])
Hypersensitivity to drugs
Item
1. intolerance / hypersensitivity to one of the drugs (including active substances, metabolites and excipients) in this study including oral paliperidone and aripiprazole and/or hypersensitivity to risperidone.
boolean
C0020517 (UMLS CUI [1,1])
C0753678 (UMLS CUI [1,2])
C0073393 (UMLS CUI [2,1])
C0020517 (UMLS CUI [2,2])
C0753678 (UMLS CUI [1,2])
C0073393 (UMLS CUI [2,1])
C0020517 (UMLS CUI [2,2])
Pregnancy or lactation
Item
2. pregnancy or lactation.
boolean
C2986850 (UMLS CUI [1])
Clozapine
Item
3. patients who are currently using clozapine.
boolean
C0009079 (UMLS CUI [1])
patients who do not fully comprehend the purpose or are not competent to make a rational decision whether or not to participate.
Item
4. patients who do not fully comprehend the purpose or are not competent to make a rational decision whether or not to participate.
boolean
C1321605 (UMLS CUI [1])
Medication intolerance
Item
5. patients with a documented history of intolerance to any of the study medications and/or a documented history of non-response to a treatment with one of the study drugs of at least 6 weeks within the registered dose range.
boolean
C2321306 (UMLS CUI [1])
Forensic patients
Item
6. forensic patients.
boolean
C0016558 (UMLS CUI [1,1])
C0030705 (UMLS CUI [1,2])
C0030705 (UMLS CUI [1,2])
Investigational drug
Item
7. patients who have been treated with an investigational drug within 30 days prior to screening.
boolean
Simultaneous participation in another intervention study
Item
8. simultaneous participation in another intervention study (neither medication or psychosocial intervention).
boolean
C2348568 (UMLS CUI [1])